4,4,5,5-Tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane - CAS 126689-04-1
Catalog: |
BB057468 |
Product Name: |
4,4,5,5-Tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane |
CAS: |
126689-04-1 |
Synonyms: |
4,4,5,5-tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane; 4,4,5,5-tetramethyl-2-(1-methyl-cyclopropyl)-[1,3,2]dioxaborolane; 1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-(1-methylcyclopropyl)- |
IUPAC Name: | 4,4,5,5-tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane |
Description: | 4,4,5,5-Tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane, is cyclopropylbronate derivative, which can be used in the synthesis of variety of cyclic and acyclic organic compounds. |
Molecular Weight: | 182.07 |
Molecular Formula: | C10H19BO2 |
Canonical SMILES: | B1(OC(C(O1)(C)C)(C)C)C2(CC2)C |
InChI: | InChI=1S/C10H19BO2/c1-8(2)9(3,4)13-11(12-8)10(5)6-7-10/h6-7H2,1-5H3 |
InChI Key: | SBMUAPREBINNKY-UHFFFAOYSA-N |
References: | Salaun, J. et al. Topics in Curr. Chem. 1, 144 (1988). |
GHS Hazard Statement: | H227 (100%): Combustible liquid [Warning Flammable liquids] |
Precautionary Statement: | P210, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P370+P378, P403, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2020172539-A1 | Azalactam Compounds as HPK1 Inhibitors | 20181115 |
WO-2020100027-A1 | 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer | 20181115 |
AU-2019378184-A1 | 2,3-dihydro-1H-pyrrolo(3,4-c)pyridin-1-one derivatives as HPK1 inhibitors for the treatment of cancer | 20181115 |
BR-112021008991-A2 | 2,3-dihydro-1h-pyrrolo[3,4c]pyridin-1-one derivatives as hpk1 inhibitors for cancer treatment | 20181115 |
EP-3880676-A1 | 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer | 20181115 |
IL-283149-D0 | Inhibitors of hpk1 and their use in the treatment of cancer | 20181115 |
KR-20210090675-A | 2,3-dihydro-1H-pyrrolo[3,4-C]pyridin-1-one derivatives as HPK1 inhibitors for the treatment of cancer | 20181115 |
US-11142525-B2 | Azalactam compounds as HPK1 inhibitors | 20181115 |
JP-2022507231-A | 2,3-Dihydro-1H-pyrrolo [3,4-c] pyridin-1-one derivative as an HPK1 inhibitor for the treatment of cancer | 20181115 |
JP-2022505562-A | Compounds and compositions for treating conditions associated with NLRP activity | 20181024 |
Complexity: | 215 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 182.14781 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 182.14781 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 18.5Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS